DaehanPharmaceutical Logo

DaehanPharmaceutical

Develops and manufactures pharmaceuticals and health foods for human and animal markets worldwide.

023910 | KO

Overview

Corporate Details

ISIN(s):
KR7023910003
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 선유로45길 3, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daehan New Pharm Co., Ltd. is a pharmaceutical company that develops, manufactures, and markets a diverse portfolio of healthcare products. Established in 1984 with an initial focus on animal medicine, the company has expanded its operations to four core business areas: human pharmaceuticals, animal pharmaceuticals, biopharmaceuticals, and health functional foods. Its product lines include a range of therapeutic agents, antibiotics, vaccines, and specialized products for both livestock and companion animals. The company places a strong emphasis on innovation, operating dedicated research institutes that focus on next-generation technologies, including cell therapy and anti-aging solutions, for both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-09-02 00:00
Interim Report
[기재정정]반기보고서 (2025.06)
Korean 840.3 KB
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 816.8 KB
2025-07-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 121.1 KB
2025-05-27 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 770.8 KB
2025-04-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-04-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-04-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 174.0 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.5 KB
2025-03-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.0 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 19.0 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 956.2 KB

Automate Your Workflow. Get a real-time feed of all DaehanPharmaceutical filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DaehanPharmaceutical

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DaehanPharmaceutical via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.